Alentis Therapeutics alentis.ch


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Alentis Therapeutics is a biotech company that discovers and develops medications to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).

Alentis Therapeutics is a biotech company that discovers and develops medications to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).

Company (Alive / Active)

Phone: +49 157 5877 9471

Fax:

Hochbergstrasse 60C

Basel, 4057
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alentis Therapeutics $12.3M Apr 30, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alentis Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
High-Tech GrunderfondsVenture CapitalBonn, GermanySeries A
BioMedPartnersVenture CapitalZurich, SwitzerlandSeries A
BPI FranceDiversified Financial ServicesMaisons-Alfort, FranceSeries A
Schroder AdveqAsset/Investment ManagementZurich, SwitzerlandSeries A
Pureos BioventuresVenture CapitalKusnacht, SwitzerlandSeries A
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)